Winton Group’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-276,948
Closed -$3.56M 1098
2025
Q3
$3.56M Buy
+276,948
New +$3.69M 0.13% 211
2024
Q3
Sell
-44,305
Closed -$837K 754
2024
Q2
$837K Sell
44,305
-331,745
-88% -$5.66M 0.06% 358
2024
Q1
$6.11M Buy
+376,050
New +$5.51M 0.43% 38
2023
Q3
Sell
-99,767
Closed -$1.71M 915
2023
Q2
$1.71M Buy
99,767
+69,100
+225% +$1.07M 0.14% 118
2023
Q1
$427K Buy
30,667
+5,284
+21% +$77.8K 0.03% 745
2022
Q4
$340K Buy
+25,383
New +$328K 0.02% 757
2022
Q2
Sell
-309,076
Closed -$4M 1068
2022
Q1
$4M Buy
+309,076
New +$4.08M 0.21% 90
2021
Q4
Sell
-24,063
Closed -$469K 1351
2021
Q3
$469K Sell
24,063
-4,727
-16% -$93.8K 0.03% 889
2021
Q2
$656K Buy
28,790
+3,914
+16% +$81.2K 0.04% 765
2021
Q1
$457K Buy
+24,876
New +$408K 0.03% 937
2020
Q3
Sell
-123,173
Closed -$978K 1600
2020
Q2
$978K Sell
123,173
-232,615
-65% -$1.93M 0.03% 976
2020
Q1
$2.88M Buy
+355,788
New +$4.23M 0.08% 448
2019
Q4
Sell
-739,122
Closed -$6.6M 1747
2019
Q3
$6.6M Buy
739,122
+703,288
+1,963% +$6.15M 0.08% 293
2019
Q2
$306K Buy
+35,834
New +$283K 0.01% 888

Other funds holding SEM

Winton Group's SEM Position: Q4 2025 in Review

Winton Group sold out of Select Medical (SEM) in Q4 2025, closing a stake of 276,948 shares — an estimated $3.56M sold.

Winton Group first reported a position in SEM in Q2 2019 and held it in 14 quarters. The position peaked at $6.6M in Q3 2019. 268 funds tracked by Wall St. Rank hold SEM as of Q4 2025.

  • Winton Group reported no remaining Select Medical position as of Q4 2025 after selling out during the quarter.
  • Winton Group sold 276,948 Select Medical shares in Q4 2025, an estimated $3.56M.
  • Winton Group first reported a position in Select Medical in Q2 2019 and held it in 14 quarters.
  • Winton Group's Select Medical position peaked at $6.6M in Q3 2019.
  • 268 funds tracked by Wall St. Rank held Select Medical as of Q4 2025.

Based on Winton Group's 13F filing for Q4 2025, filed 11 Feb 2026.